Prevention of STAT3-related pathway in SK-N-SH cells by natural product astaxanthin
Open Access
- 29 November 2023
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-11
Abstract
Purpose: Neuroblastoma (NB) is the most common solid malignancy in children. Despite current intensive treatment, the long-term event-free survival rate is less than 50% in these patients. Thus, patients with NB urgently need more valid treatment strategies. Previous research has shown that STAT3 may be an effective target in high-risk NB patients. However, there are no effective inhibitors in clinical evaluation with low toxicity and few side effects. Astaxanthin is a safe and natural anticancer product. In this study, we investigated whether astaxanthin could exert antitumor effects in the SK-N-SH neuroblastoma cancer cell line. Method: MTT and colony formation assays were used to determine the effect of astaxanthin on the proliferation and colony formation of SK-N-SH cells. Flow cytometry assays were used to detect the apoptosis of SK-N-SH cells. The migration and invasion ability of SK-N-SH cells were detected by migration and invasion assays. Western blot and RT-PCR were used to detect the protein and mRNA levels. Animal experiments were carried out and cell apoptosis in tissues were assessed using a TUNEL assay. Result: We confirmed that astaxanthin repressed proliferation, clone formation ability, migration and invasion and induced apoptosis in SK-N-SH cells through the STAT3 pathway. Furthermore, the highest inhibitory effect was observed when astaxanthin was combined with si-STAT3. The reason for this may be that the combination of astaxanthin and si-STAT3 can lower STAT3 expression further than astaxanthin or si-STAT3 alone. Conclusion: Astaxanthin can exert anti-tumor effect on SK-N-SH cells. The inhibitory effect was the higher when astaxanthin was combined with si-STAT3.Keywords
Funding Information
- the Scientific Research Common Program of the Beijing Municipal Commission of Education (No. KM201911417013, No. KM202111417011)
- the Premium Funding Project for Academic Human Resources Development in Beijing Union University (No. BPHR2019DZ04)
- the Venus Research Training Students Program (x202211417050)
This publication has 45 references indexed in Scilit:
- Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathwaysOncology Reports, 2011
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitorBlood, 2011
- Expression of Concern: A small molecule, LLL12 inhibits constitutive STAT3 and IL‐6‐induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cellsInternational Journal of Cancer, 2011
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Targeting STAT3 in cancer: how successful are we?Expert Opinion on Investigational Drugs, 2008
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cellsCancer Chemotherapy and Pharmacology, 2008
- Tamoxifen Stimulates the Growth of Cyclin D1–Overexpressing Breast Cancer Cells by Promoting the Activation of Signal Transducer and Activator of Transcription 3Cancer Research, 2008
- STAT3 as a target for inducing apoptosis in solid and hematological tumorsCell Research, 2008
- Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian CancerClinical Cancer Research, 2006
- Haematococcus astaxanthin: applications for human health and nutritionTrends in Biotechnology, 2003